drugset / Trial / NCT04950608
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Phase 2
Completed
15 enrolled
Yvan Beaussant, MD, MSci
Carey and Claudia Turnbull Family Foundation · collabCouncil on Spiritual Practices Fund at the San Francisco Foundation · collabGeorge Sarlo Foundation · collabHeffter Research Institute · collabJack Smith · collabNikean Foundation · collabOppenheimer Family Psychosocial Oncology and Palliative Care Research Grants · collabRiverStyx Foundation · collabUsona Institute · collab
NaSingle-groupOpen-labelTreatment
Summary
The overall objective of this study is to develop and pilot test a novel regimen of psilocybin-assisted psychotherapy for demoralization in patients receiving hospice care. -The name of the study drug involved in this study is Psilocybin
Timeline
- Start
- 2022-03-09
- Primary completion
- 2024-07-27
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 25 mg | Oral |